All In Biotech

Drug Trial Radar · NCT07727538

A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants

An Open-Label Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Pediatric Patients With Familial Chylomicronemia Syndrome (FCS)

Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

12

Planned (sponsor's estimate)

Start

Jul 31, 2026

Primary completion

Aug 2030

Study completion Aug 2031

Sponsor

Lead sponsor
Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
Sponsor type
Industry
First posted
Jul 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of the study is to evaluate the efficacy of olezarsen administered by subcutaneous injection to pediatric participants with FCS.

Conditions

  • Familial Chylomicronemia Syndrome

Interventions

  • OlezarsenDrug

    Olezarsen will be administered by subcutaneous injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change from Baseline in Fasting Triglycerides (TG)Time frame: At 6 Months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama

    Birmingham, Alabama · Recruiting

  • UCSF Benioff Children's Hospital

    San Francisco, California · Recruiting

  • Children's Mercy Hospital

    Kansas City, Missouri · Recruiting

  • University of Texas Southwestern Medical Center

    Dallas, Texas · Recruiting

  • Cook Children's Medical Center

    Fort Worth, Texas · Recruiting

  • Mary Bridge Children's

    Tacoma, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.